To examine the contribution of Non-Esterified Fatty-Acids (NEFA) and incretin to insulin-27 resistance and diabetes amelioration after malabsorptive metabolic-surgery that induces steatorrhea. 28 In fact, NEFA infusion reduces glucose-stimulated insulin secretion and high-fat diets predict 29 diabetes development. Six healthy-controls, 11 obese and 10 Type-2-Diabetic (T2D) subjects were 30 studied before and 1 month after Bilio-Pancreatic Diversion (BPD). Twenty-four hours plasma 31 glucose, NEFA, insulin, C-peptide, glucagon-like peptide-1 (GLP1) and gastric-inhibitory-32 polypeptide (GIP) time courses were obtained and analyzed by Granger causality and graph 33 analyses. Insulin sensitivity and secretion were computed by the oral glucose minimal-model.
3

INTRODUCTION
The X component at time t, X t , is assumed to depend on the past of Y according to the 
where and are, in general, random vectors, , and , are matrices, is a noise term 142 (regression residuals), and p is the model order. In particular, there is no conditional dependence of 143 X on the past of Y (reduced regression) if 144 A xy,1 = A xy,2 = · · · = A xy,p = 0.
145 Therefore, technically, the G-causality is a test statistic for the null hypothesis of zero causality: 146 H 0 : A xy,1 = A xy,2 = · · · = A xy,p = 0, (2) 147 and the null hypothesis will be rejected if the inclusion of the Y-term in Eq. (1) substantially 148 improves the fitting capacity of the model.
In the presence of multivariate processes with variables X, Y and Z, where Z is an 150 exogenous variable that affects X and Y, the full and reduced regressions for the X component are 151 represented as: (4) =1 According to Eqs.
(3) and (4), the G-causality from Y to X, F Y  X|Z , is defined as
where  = cov( , ),  ′ = cov( , ′ ), and |  | denotes the determinant of the enclosed matrix. 155 The determinants in the numerator and the denominator in the right-hand-side of Eq. is included in the model for X. 159 As the conditioning variable Z is present in both Eqs.
(3) and (4), the confounding effect of 160 Z on the assessment of G-causality for X and Y can be eliminated. Thus, the method allows for the 161 conditioning out of common causal influences and F Y  X|Z may be read as "the degree to which the 162 past of Y helps predict X, over and above the degree to which X is already predicted by its own past 163 and the past of Z", see ref.
(2). However, in the presence of dependencies on exogenous inputs that 164 are not measured, as it occurs in this study because the meals directly affect glucose and NEFA 165 concentrations, the complete elimination of the confounding effects of these inputs on the 166 assessment of G-causality cannot be achieved. The quantities F of the type reported in Eq. (5) may be considered as a weighted directed graph linking the vertexes X, Y and Z, and we can thus obtain 168 a (G-)causal graph.
169
In summary, the type of analysis described above tries to establish whether the previous 170 values of a time-changing variable Y, in our case the concentration of a metabolite or 171 hormone, improve the prediction of another variable X compared to the prediction of X based only 172 on its own previous values (equations (1) and (3)). This method so extends the usual notion of 173 correlation to the stronger notion of G-causality (improved predictability of X, given the precedent 174 values of Y Criterion, which provides a balance between the goodness of fit of the model to data and the 183 number of parameters to be estimated.
184
Graph indexes 185 The aim of the centrality measures in network analysis is that of determining the relative 186 importance of a vertex within the graph (4). In our study, we consider two measures of centrality, 187 degree and betweenness, and two measures typical of the network: density and efficiency.
188
In degree is the sum of the weights of the edges going into a node and the out degree is the 
RESULTS
224
Weight and body composition 225 The anthropometric data are summarized in Table 1 . The patients lost a significant amount 226 of weight after BPD. The weight loss was much more pronounced in obese subjects with normal 227 glucose tolerance than in T2D patients. All patients lost both lean and fat mass, although the effect 228 of bariatric surgery was stronger on fat mass reduction.
229
Glycated hemoglobin was significantly improved after BPD, in particular in T2D patients. edges. The value of the betweenness of a node is indicated by a color. The dominant variable/s have a red color. As soon as the dominance of betweenness becomes less strong, the color is lighter, from 246 orange to yellow. Some of the hedges are unidirectional, as also shown by the adjacency matrixes.
247
In the obese subjects before bariatric surgery NEFA have the strongest influence on the 248 other variables while, after surgery, GLP1 and C-peptide, i.e., the insulin secretion, play a central 249 role. Also in the obese diabetic subjects, NEFA dominates over the other variables, but after 250 bariatric surgery, GLP1 controls the system. In the healthy controls, finally, NEFA, GLP1 and C-251 peptide have a comparable relevance in the network.
252 Table 2 reports the numerical values of the betweenness (also shown by the color code in diabetic subjects, the betweenness of GLP1 remains significantly lower than that of controls.
265
In obese subjects, the in degrees increase significantly for C-peptide, GLP1 and GIP while 266 decrease for glucose and insulin; the out degrees diminish only for NEFA and insulin, and raise 267 only for GIP. No significant differences occur between obese post BPD and controls. Total degrees 268 significantly increase post BPD for C-peptide, GLP1 and GIP. On the contrary, they decrease for 269 glucose, NEFA and insulin. However, the total degrees of insulin and GLP1 remain lower 270 compared with those of controls.
271
In diabetic subjects, the in degrees decrease for insulin and C-peptide and increase for 272 GLP1, the out degrees lower for glucose, insulin and C-peptide and heighten for NEFA and GLP1; obese and diabetic subjects the total degrees decrease in glucose and insulin, and increase in GLP1.
278
The graph density significantly increases after surgery in the obese subjects (Student's t-
279
test=8.32, P<0.001) and the graph efficiency increases (t=5.64, P<0.001). In T2D subjects, graph Table 1 reports S I , S G and cumulative insulin secretion (AUC ISR ).
286
Insulin sensitivity increases more than 5 times in obese and 4 times in T2D subjects after 287 BPD, matching the values observed in healthy controls. The cumulative insulin secretion decreases 288 significantly in T2D subjects after BPD and even halves in obese subjects.
289
Robustness analysis 290
The adjacency matrixes computed by the Bootstrap method were marginally changed with 291 respect to those shown in Fig. 2 . The degrees computed by this method were not significantly 292 different from those reported in Table 2 . When the Granger analysis was applied to the time-course of the variables perturbed by noise the total degrees tended to decrease, but the difference of total 294 degrees from before to after BPD remained rather stable as shown in the Figure 2 of the Appendix, 295 so the changes from before to after BPD reflect substantially those in Table 2 . In his study, we set up a graphical approach that models, identifies and visualizes the causal 300 relationships between the components of data recorded during a 24-hour multi-meal test. Glucose, 301 insulin, C-peptide, NEFA, GLP-1 and GIP concentrations were measured in T2D and in obese 302 normoglycemic subjects, before and after malabsorptive metabolic surgery, and in healthy controls.
303
Data were analyzed by the Granger causality method and graph analysis, which are widely 304 used for instance in exploring multivariate time series of economic data (8) and brain networks (11).
305
Our analysis permitted to establish the degree of association among the metabolic and hormonal The Granger and graph methods do not require a model that describes the underlying 312 physiology of the glucose-insulin system, and use all the recorded data simultaneously to reveal the 313 mutual influences among the variables recorded. Therefore, it may capture features in response to 314 the meals that are hardly detectable by a particular mathematical model.
315
Limitations of our study are that Granger causality is a statistical inference on the 316 relationships among variables but do not necessarily imply physical causality which needs to be 317 determined by an interventional experiment. However, the introduction of causality rules, as in the 318 Granger causality, may provide a means to distinguish whether any of our variables interact directly 319 or whether the appearance of a correlation is a result of chance or the variables are forced by a 320 common third variable. Another limitation is the lack of data on glucagon concentrations, which is a 321 major player in type 2 diabetes with GIP increasing glucagon circulating levels in type 2 diabetes 322 (43). Finally, we stress that the use of splines to interpolate our hourly data might bias the analysis. may indeed be missed because of the spline approximation that produces a smoothing in the time- 
338
BPD is a mainly malabsorptive metabolic operation that greatly reduces lipid absorption 339 and, thus, its action in improving insulin sensitivity might depend on the reduction of circulating 340 levels of NEFA. However, here we show that it is the increase in GLP1 plasma levels, rather than 341 the reduction of NEFA circulating levels, which drives the reduction of plasma glucose and insulin 342 over 24 hours. Rather than finding a reduction of plasma NEFA we found unchanged or sometime 343 slightly increased levels. Fasting and low energy intake are associated with increased circulating 344 levels of NEFA. In fact, the highest plasma NEFA concentrations are observed after an overnight 345 fast, with suppression after each meal (37, 27, 39). During energy deprivation, adipose tissue 346 lipolysis is increased with generation of fatty acids and glycerol, which are released into the 347 circulatory stream for use by other organs as energy substrates. Food deprivation in rats is 348 associated with doubled hormone sensitive lipase protein expression and activity in the adipose tissue (46). After bariatric surgery it was reported that all lipids in tissues and plasma diminished 350 except plasma NEFA, which maintained higher levels than controls (35). Therefore, NEFA plasma 351 levels remained elevated after bariatric surgery due to energy intake restriction and weight loss.
352
In addition, the high plasma levels of GIP observed in T2D subjects at baseline were 353 detrimental for their glucose metabolism. GIP signaling, in fact, promotes fat accumulation in 354 experimental animals (19, 22, 23, 24, 26, 33) . Obese humans also hyper-secrete GIP (10, 13) 355 suggesting that GIP may promote obesity in humans. GIP receptor knockout rodents are protected 356 from obesity-related diabetes (32), as well animals genetically engineered to lack K cells also resist 357 development of high fat diet-induced obesity and insulin resistance without any collateral serious 358 adverse effect (1) . Furthermore, chronic administration of (Pro 3 GIP), a specific and stable GIP 359 receptor antagonist, can prevent or reverse many of the established metabolic alterations, including 360 insulin resistance, observed in type 2 diabetes (15).
361
In the present study, both T2D and normoglycemic obese patients had the normalization of 362 insulin resistance just 1 month after BPD. In addition, glycated hemoglobin was drastically reduced 363 after BPD in T2D patients (Table 1) . Likewise, a very low calorie diet administered to T2D patients 364 for 1 month was effective in improving glycated hemoglobin (20).
365
In conclusion, increased GLP1 circulating levels over 24 hours positively impact on glucose 366 homeostasis in both obese and obese diabetic individuals who underwent a malabsorptive operation.
367
The reduction of plasma GIP also contributed to the improvement of glucose metabolism. It is 368 possible that the combination of a pharmaceutical treatment reducing GIP and increasing GLP1 369 plasma levels will contribute to a better glycemic control in type 2 diabetes. Indeed, recent findings 
